Home › Microbiology › Human Parainfluenza Virus

Human Parainfluenza Virus

Human parainfluenza viruses

For medical students2 min readUpdated 2026-10-10

Human parainfluenza viruses are agents of acute viral respiratory infections that predominantly target the upper respiratory tract, with the larynx being the primary clinical target. The disease is characterized by rapid inflammatory development and can cause severe forms of croup (laryngotracheobronchitis) in children.

FamilyParamyxoviridae (RNA-containing)

Primary targetLaryngeal and respiratory epithelium

Incubation3 to 6 days

ImmunityShort-lived, type-specific

Taxonomy and Virion Structure

The pathogen belongs to the family Paramyxoviridae. These agents were first discovered by R. Chanock in 1956. They are divided into two genera: Respirovirus (includes serotypes 1 and 3) and Rubulavirus (includes serotypes 2, 4a, and 4b).

The genetic material is represented by a single-stranded, non-segmented negative-sense RNA (-ssRNA), which encodes seven different proteins. The internal viral antigen is the nucleocapsid, tightly associated with the matrix (M) protein. Externally, the virion is covered by a lipoprotein envelope (supercapsid) bearing critical glycoprotein spikes on its surface:

HN (Hemagglutinin-Neuraminidase) — a surface antigen responsible for viral attachment.
F (Fusion protein) — mediates virus entry into the host cell.

Antigenic Properties and Cultivation

Based on structural differences in key proteins (HN, NP, and F), four main serotypes are distinguished: HPIV-1, HPIV-2, HPIV-3, and HPIV-4. Notably, the first three types share cross-reactive antigens with the mumps virus, which can lead to cross-reactive immunological responses.

All serotypes possess hemagglutinin, but their spectrum of activity varies significantly:

HPIV-1 and HPIV-2 can agglutinate human, chicken, and guinea pig erythrocytes.
HPIV-3 does not interact with chicken erythrocytes.
HPIV-4 causes agglutination exclusively of guinea pig erythrocytes.

Propagation of the pathogen in laboratory conditions is primarily performed in primary cell cultures. In the external environment, the viruses show low stability, which is typical for the entire paramyxovirus family.

Epidemiology and Pathogenesis

The source of infection is always an infected human. The primary transmission route is airborne (droplet), although contact transmission is also possible. The infection is widespread, with types 1, 2, and 3 predominating. The infection is highly contagious, meaning the vast majority of adults already possess antibodies. Unlike classic influenza, there is no distinct seasonal pattern.

The portal of entry is the mucous membrane of the upper respiratory tract. The virus adsorbs onto epithelial cells, replicates within them, and leads to their destruction. The inflammatory process can rapidly spread to the lower regions of the respiratory tract.

The infection is accompanied by a brief viremia and systemic intoxication caused by cellular breakdown products. A secondary immunodeficiency also develops, significantly increasing the risk of bacterial superinfections.

Clinical Presentation

The incubation period lasts from 3 to 6 days. The onset of the illness is marked by fever, systemic intoxication syndrome (headache, malaise), and catarrhal symptoms such as cough and rhinorrhea.

The clinical course heavily depends on the patient's age and the specific viral serotype:

In adults, the pathology most often presents as mild to moderate laryngitis.
In children, the infection can take severe forms. HPIV-1 and HPIV-2 are the primary causes of a dangerous condition: croup (acute laryngotracheobronchitis). Meanwhile, HPIV-3 frequently causes focal pneumonia.

Diagnosis, Treatment, and Prevention

Mucus, respiratory secretions, or sputum are typically collected for laboratory analysis.

Microbiological diagnosis includes:

Virological assay — considered the "gold standard." It is performed in cell cultures. Viral identification is evaluated via cytopathic effect (CPE), hemagglutination assay (HA), and most importantly, the hemadsorption phenomenon.
Identification is performed using hemagglutination inhibition assay (HI), complement fixation test (CFT), and neutralization assay.
Serological assays are used both for rapid viral antigen detection and retrospective assessment of rising antibody titers in paired sera.

Specific prophylaxis (vaccination) is currently unavailable; only sanitary and hygienic measures are applied. Treatment is largely supportive, although antiviral drugs (e.g., umifenovir), interferons, and immunomodulators may be included in management regimens.

Mnemonic

To remember which types are dangerous for children, use the phrase: "First two cause croup, third causes pneumonia deep." This reflects the tendency of types 1 and 2 to cause laryngotracheobronchitis, and type 3 to cause focal pneumonia.

Frequently asked questions

What is the pathogenesis of croup (stenosing laryngotracheitis) caused by parainfluenza in children?

The pathogenesis of croup in parainfluenza involves mechanical narrowing of the airways, leading to progressive respiratory failure. The syndrome is driven by the following local processes:

Inflammation and edema — involvement of the laryngeal mucosa and subglottic space.
Mucus accumulation — production of thick secretions that prevent the complete closure of the vocal cords during phonation.

The mechanism of this complication is similar to influenza-associated croup. Clinically, it manifests as dysphonia, a characteristic "barking" cough, and noisy stenotic breathing accompanied by the use of accessory respiratory muscles.

Which bacterial complications most commonly develop secondary to immunodeficiency during parainfluenza infection?

Secondary to immune suppression, epithelial damage, and compromised local immune barriers during parainfluenza infection, the risk of secondary bacterial complications increases. Major pathogens implicated in these respiratory viral superinfections include:

Haemophilus influenzae;
Streptococcus pneumoniae;
Moraxella catarrhalis.

Primary viral epithelial damage paves the way for secondary bacterial infection; pneumonias in acute respiratory viral infections can be primarily viral or secondarily bacterial.

At what time interval should paired sera be collected for retrospective serological diagnosis of parainfluenza?

For retrospective serological diagnosis of parainfluenza, paired sera should be collected at an interval of 10–14 days. The diagnostic criterion confirming infection is a 4-fold or greater rise in specific antibody titers. Testing is performed using assays such as neutralization, complement fixation, passive hemagglutination inhibition, and ELISA. The clinical value of this method is primarily retrospective and epidemiological, as the duration of the illness itself (typically 5–7 days) is shorter than the time required to generate diagnostically significant antibody titers.

Can a person get infected with parainfluenza again?

Yes. Post-infection immunity is weak, short-lived, and strictly type-specific, meaning reinfection even with the same viral types is possible.

Why might a false-positive reaction for mumps occur during diagnosis?

HPIV serotypes 1, 2, and 3 share common antigenic structures with the mumps virus, which leads to cross-reactions with antibodies directed against the mumps pathogen.

What is the most crucial criterion when identifying the virus in cell culture?

The most important criterion during cultivation is the hemadsorption phenomenon, which is especially characteristic of HPIV-1, -2, and -3 (historically referred to as hemadsorbing viruses).

Go deeper

Molecular mechanisms of HN and F protein functions during cell adsorption and penetration.
Differential diagnosis of viral croup versus true croup (diphtheria).
Mechanisms of secondary immunodeficiency formation during paramyxovirus infections.
Principles of setting up HI, CFT, and neutralization assays for viral agent identification.
Comparison of the cytopathic effects of parainfluenza versus influenza viruses in cell cultures.